Cannabis was on the ballot in five US states yesterday as part of the 2022 midterm elections. Of those five,…
McAlinden Research PartnersNovember 9, 2022
Mergers and Acquisitions in the biopharma space continue to heat up, fueling a significant increase in large deals through the first 9…
McAlinden Research PartnersOctober 19, 2022
A month on from Ethereum's (ETH) highly-anticipated "Merge", the network has proven to be quite resilient since making the jump…
McAlinden Research PartnersOctober 18, 2022
DraftKings is reportedly in talks for an unprecedented partnership with ESPN, the most recognizable name in sports broadcasting. That is…
McAlinden Research PartnersOctober 12, 2022
Rising nominal rates are clearly putting pressure on economic growth in the US. The Fed has become more aggressive as…
McAlinden Research PartnersOctober 4, 2022
The US's first marketed CRISPR drug may be set to make its debut in a year or less, following CRISPR…
McAlinden Research PartnersSeptember 29, 2022
The UK's Pound Sterling (GBP) plummeted yesterday, recording one of its worst days of trading across the past three decades. Moreover,…
McAlinden Research PartnersSeptember 27, 2022
Vertical farming is widely viewed as the preeminent form of indoor farming, maximizing water-efficiency and aiding the management of other…
McAlinden Research PartnersSeptember 7, 2022
The glow of Zoom and other stocks that boomed on the "work from home" trade has faded in 2022 amid a…
McAlinden Research PartnersAugust 23, 2022
